Literature DB >> 9258880

Response of the primate secretory endometrium to subchronic hypercortisolemia.

W B Kowalski1, R F Valle, R T Chatterton.   

Abstract

OBJECTIVE: To assess the impact of subchronic and moderate hypercortisolism on the secretory endometrium of the cynomolgus monkey.
METHODS: Osmotic pumps containing hydrocortisone phosphate (HP) were implanted subcutaneously in each monkey on the first day of the menstrual cycle; each monkey also received pumps containing saline in another cycle. Blood was obtained three times per week and urine was collected daily for hormone analyses. Endometriectomy was performed 13 +/- 1 days after the serum estradiol (E2) peak in each study cycle.
RESULTS: Infusion of HP elevated serum cortisol levels by an average of 70%. Mean serum progesterone (P) levels were decreased by 50% during the secretory phase of HP-treatment cycles by comparison with self-control cycles (P < .01); as a result, the mean endometrial glycogen concentration was reduced by 30% (P < .05) and the activity of 17 beta-hydroxysteroid dehydrogenase was decreased by 70% (P < .05). Serum E2 levels were not consistently elevated by HP treatment, but cytosolic estrogen receptor levels of the endometrium were decreased by 50% (P < .01), indicating increased estrogenic stimulation. Histologic development of the secretory endometrium was retarded, but the length of the secretory phase was not affected by the treatment.
CONCLUSION: A moderate elevation of serum cortisol levels over one menstrual cycle consistently produced a reduction in serum P and a hypoprogestogenic-hyperestrogenic response of the secretory endometrium in the cynomolgus monkey.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9258880     DOI: 10.1016/s1071-5576(97)00018-x

Source DB:  PubMed          Journal:  J Soc Gynecol Investig        ISSN: 1071-5576


  2 in total

1.  The Plasminogen Activator System, Glucocorticoid, and Mineralocorticoid Receptors in the Primate Endometrium During Artificial Menstrual Cycles.

Authors:  Esra Demirel; Reem Sabouni; Neelima Chandra; Ov D Slayden; David F Archer
Journal:  Reprod Sci       Date:  2021-11-18       Impact factor: 3.060

2.  Protection against high-dose highly pathogenic mucosal SIV challenge at very low serum neutralizing titers of the antibody-like molecule CD4-IgG2.

Authors:  Pascal Poignard; Brian Moldt; Karla Maloveste; Noëlie Campos; William C Olson; Eva Rakasz; David I Watkins; Dennis R Burton
Journal:  PLoS One       Date:  2012-07-27       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.